4//SEC Filing
CYTOMEDIX INC 4
Accession 0001292660-14-000001
$AURXCIK 0001091596operating
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:08 PM ET
Size
16.2 KB
Accession
0001292660-14-000001
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI
Kent Richard S
Director
Transactions
- Award
Option to purchase shares of Common Stock
2014-01-28+30,000→ 30,000 totalExercise: $0.61Exp: 2024-01-28→ Common Stock (30,000 underlying)
Holdings
- 30,000
Option to purchase shares of Common Stock
Exercise: $0.51From: 2013-03-19Exp: 2023-03-19→ Common Stock (30,000 underlying) - 224,849(indirect: by Intersouth Partners VII, L.P.)
Warrant (right to buy)
Exercise: $0.75From: 2013-02-22Exp: 2018-02-21→ Common Stock (224,849 underlying) - 1,233,738(indirect: by Intersouth Partners VI, L.P.)
Common Stock
- 1,233,740(indirect: by Intersouth Partners VII, L.P.)
Common Stock
- 495,538(indirect: by Intersouth Partners VII, L.P.)
Warrant
Exercise: $1.42Exp: 2014-12-31→ Common Stock (495,538 underlying) - 224,848(indirect: by Intersouth Partners VI, L.P.)
Warrant (right to buy)
Exercise: $0.75From: 2013-02-22Exp: 2018-02-21→ Common Stock (224,848 underlying) - 64,859(indirect: by Intersouth Partners VI, L.P.)
Warrant
Exercise: $1.42Exp: 2014-12-31→ Common Stock (64,859 underlying)
Footnotes (6)
- [F1]The reportable securities are owned directly by Intersouth Partners VI, L.P. ("ISP VI"). The shares directly held by ISP VI are indirectly held by Intersouth Associates VI, LLC ("ISA VI"), as general partner of ISP VI, and each of the individual managing members of ISA VI. The individual managing members (collectively, the "ISA VI Member Managers") of ISA VI are Mitch Mumma and Dennis Dougherty. ISA VI Member Managers may share voting and dispositive power over the shares directly held by ISP VI. Dr. Kent is a member of ISA VI, the general partner of ISP VI. Dr. Kent disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
- [F2]The reportable securities are owned directly by Intersouth Partners VII, L.P. ("ISP VII"). The shares directly held by ISP VII are indirectly held by Intersouth Associates VII, LLC ("ISA VII"), as general partner of ISP VII, and each of the individual managing members of ISA VII. The individual managing members (collectively, the "ISA VII Member Managers") of ISA VII are Mitch Mumma and Dennis Dougherty. ISA VII Member Managers may share voting and dispositive power over the shares directly held by ISP VII. Dr. Kent is a member of ISA VII, the general partner of ISP VII. Dr. Kent disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.
- [F3]Represents annual Board member compensation pursuant to the Company's 2013 Equity Incentive Plan. The options vest monthly in 1/12 increments through 2014.
- [F4]Director compensation approved by the Company's Board of Directors.
- [F5]Represents annual Board member compensation pursuant to the Company's Long-Term Incentive Plan. The options vest monthly in 1/12 increments throughout 2013.
- [F6]30% of the warrant is exercisable commencing on February 8, 2012, and the remaining balance of the warrant, upon issuance of the Third Post-Closing Consideration (as defined and set forth in Section 2.4 of the Exchange and Purchase Agreement by and among Cytomedix, Inc., Aldagen, Inc. and Aldagen Holdings, LLC, dated as of February 8, 2012).
Documents
Issuer
CYTOMEDIX INC
CIK 0001091596
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001091596
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:08 PM ET
- Size
- 16.2 KB